Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Lawrence

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 8, 2024
Tracking Cryptococcal Meningitis to Monitor HIV Program Success During the Treat All Era: An Analysis of National Data in BotswanaJames Milburn, Ookeditse Ntwayagae, Rachita Suresh, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 25, 2026
Detection of Hepatitis B Virus in Cerebrospinal Fluid of People with HIV-associated Cryptococcal Meningitis in BotswanaBasetsana K S Phakedi, Bonolo B Phinius, Kesaobaka Molebatsi, et al.
AIDS (London, England)|June 27, 2020
A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and durationMelanie Alufandika, David S Lawrence, Timothée Boyer-Chammard, et al.
Mbio|August 27, 2024
Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitisKatharine E Stott, Jason T Mohabir, Katharine Bowers, et al.
The Journal of Antimicrobial Chemotherapy|November 21, 2022
Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitisKatharine E Stott, Melanie Moyo, Ajisa Ahmadu, et al.
The AAPS Journal|February 4, 2025
Pharmaceutical Sciences: Insights and Observations from Academic Chairs and Vice ChairsKristy M Ainslie, Albert A Bowers, Robert H Chichewicz, et al.
Nature Communications|March 16, 2025
APC/C-mediated ubiquitylation of extranucleosomal histone complexes lacking canonical degronsAleksandra Skrajna, Tatyana Bodrug, Raquel C Martinez-Chacin, et al.
Journal of Structural and Functional Genomics|December 7, 2007
Structural genomics of protein phosphatasesSteven C Almo, Jeffrey B Bonanno, J Michael Sauder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2025
Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in HIV-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From AfricaMelanie Moyo, David S Lawrence, James Jafali, et al.
Trials|March 25, 2026
Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trialKyla Murphy, Jeremy S Nel, Mahomed-Yunus Moosa, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 8, 2024
Tracking Cryptococcal Meningitis to Monitor HIV Program Success During the Treat All Era: An Analysis of National Data in BotswanaJames Milburn, Ookeditse Ntwayagae, Rachita Suresh, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 25, 2026
Detection of Hepatitis B Virus in Cerebrospinal Fluid of People with HIV-associated Cryptococcal Meningitis in BotswanaBasetsana K S Phakedi, Bonolo B Phinius, Kesaobaka Molebatsi, et al.
AIDS (London, England)|June 27, 2020
A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and durationMelanie Alufandika, David S Lawrence, Timothée Boyer-Chammard, et al.
Mbio|August 27, 2024
Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitisKatharine E Stott, Jason T Mohabir, Katharine Bowers, et al.
The Journal of Antimicrobial Chemotherapy|November 21, 2022
Population pharmacokinetics of liposomal amphotericin B in adults with HIV-associated cryptococcal meningoencephalitisKatharine E Stott, Melanie Moyo, Ajisa Ahmadu, et al.
The AAPS Journal|February 4, 2025
Pharmaceutical Sciences: Insights and Observations from Academic Chairs and Vice ChairsKristy M Ainslie, Albert A Bowers, Robert H Chichewicz, et al.
Nature Communications|March 16, 2025
APC/C-mediated ubiquitylation of extranucleosomal histone complexes lacking canonical degronsAleksandra Skrajna, Tatyana Bodrug, Raquel C Martinez-Chacin, et al.
Journal of Structural and Functional Genomics|December 7, 2007
Structural genomics of protein phosphatasesSteven C Almo, Jeffrey B Bonanno, J Michael Sauder, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2025
Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in HIV-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From AfricaMelanie Moyo, David S Lawrence, James Jafali, et al.
Trials|March 25, 2026
Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trialKyla Murphy, Jeremy S Nel, Mahomed-Yunus Moosa, et al.
Pageof 16